Description

MCL0020 is a potent and selective melanocortin MC4 receptor antagonist, with an IC50 of 11.63 nM. MCL0020 dose-dependently and significantly attenuates restraint stress-induced anorexia without affecting food intake[1].–80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)–COVID-19-immunoregulation–C34H39N7O4—-[1]Chaki S, et al. Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents. Eur J Pharmacol. 2003;474(1):95-101.–475498-26-1–609.72–99.93–NC([C@H](CC1=CC2=C(C=CC=C2)C=C1)NC([C@H](CCCNC(N)=N)NC([C@H](NC(C)=O)CC3=CC4=C(C=CC=C4)C=C3)=O)=O)=O–Inflammation/Immunology–DMSO : 125 mg/mL (ultrasonic)–Melanocortin Receptor–MC4R–GPCR/G Protein;Neuronal Signaling–Peptides